VICTOR E1

Related by string. * victor . victors . Victors . VICTORS . Victor : Victor Von Doom . catcher Victor Martinez . Victor Martinez . Victor Hugo . Victor Muller . VICTOR . Victor Blank . Romania Victor Hanescu . Victor Garber Alias . Victor Ashe / E1s . e1 : London E1 8AA telephone . T1 E1 T3 E3 . X.# T1 E1 T3 . T1 E1 fractional . VOIP TDM E1 . E1 E2 . E1 CLO . ROKR E1 . Motorola ROKR E1 . prostaglandin E1 * *

Related by context. Frequent words. (Click for all words.) 67 multicenter randomized double 66 placebo controlled Phase 66 Phase Ib clinical 64 Phase III randomized 64 phase IIb clinical 64 multicenter Phase 63 Pivotal Phase III 63 forodesine 63 Phase Ia 63 placebo controlled randomized 62 Pivotal Phase 62 blinded placebo controlled 62 double blinded placebo 62 multicenter randomized 62 Phase 2a clinical 62 Phase 1b clinical 62 Phase IIB 61 dose escalation trial 61 randomized placebo controlled 61 Phase III Clinical Trial 61 Pivotal Trial 61 phase IIa 61 placebo controlled 61 single ascending dose 61 phase IIb 61 IIa trial 60 placebo controlled clinical 60 Multicenter 60 primary hypercholesterolemia 60 Randomized controlled 60 multiple ascending dose 60 Completes Enrollment 60 Phase 1a 60 Hypoactive Sexual Desire Disorder 60 prospective multicenter 59 KRN# 59 Phase Ib 58 PREZISTA r 58 randomized double 58 Phase 1b 58 Phase 1b trial 58 PRECiSE 58 Phase 2b study 58 label multicenter 58 Phase IIa clinical 58 diabetic neuropathic pain 58 Phase 2a trial 58 Phase 2a 58 GSK# [001] 58 Phase III Trial 58 Clinical Trial Results 58 Fibrillex TM 58 #mg/day [001] 58 Initiates Phase 58 Diabetic Macular Edema 58 bicifadine 58 dose escalation study 58 plus dexamethasone 58 randomized controlled 58 plus methotrexate 58 NCT# 57 active comparator 57 Presents Positive 57 multicenter 57 mg QD 57 multicenter clinical 57 Cloretazine R VNP#M 57 Phase II 57 Pulmonary Arterial Hypertension 57 SCH # 57 Phase 2b clinical 57 Phase 2b trial 57 label dose escalation 57 Phase III 57 Gemzar ® 57 elagolix 57 Phenoptin 57 confirmatory Phase III 57 Patient Enrollment 57 Engerix B 56 Adalimumab 56 Pegasys ® 56 patients evaluable 56 relapsing multiple sclerosis 56 plus gemcitabine 56 phase 2a 56 KNS # 56 pharmacokinetics PK 56 Phase 2b clinical trials 56 TYGACIL 56 Traficet EN 56 interferon beta 1b 56 mg BID 56 relapsed refractory multiple myeloma 56 Sym# 56 Mipomersen 56 randomized Phase III 56 TELCYTA 56 Phase IIb trials 56 MKC# 56 Arch Intern Med

Back to home page